Antidepressant Warnings On Pediatric Suicide Need Immediate Strengthening, Cmte. Says

A joint FDA advisory committee says suicide risk warnings should be communicated to physicians and consumers while the agency re-analyzes pediatric data from antidepressant manufacturers.